US5166057A
(en)
†
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
US7465574B2
(en)
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US20030054505A1
(en)
*
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
DE69510207T3
(de)
|
1995-08-09 |
2007-02-15 |
Schweiz. Serum- & Impfinstitut Bern |
Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
|
US7485440B2
(en)
|
1995-09-27 |
2009-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
US6689367B1
(en)
|
1995-09-27 |
2004-02-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
US7846455B2
(en)
|
1996-07-15 |
2010-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated chimeric respiratory syncytial virus
|
DK0864645T3
(da)
|
1995-10-31 |
2005-10-24 |
Dnavec Research Inc |
Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
|
KR100525687B1
(ko)
*
|
1995-11-01 |
2005-11-25 |
가부시끼가이샤 디나벡 겡뀨쇼 |
재조합체 센다이바이러스
|
CN101012454B
(zh)
|
1996-07-15 |
2011-11-16 |
美国政府健康及人类服务部 |
从克隆的核苷酸序列制备减毒呼吸道合胞病毒疫苗的方法
|
US6699476B1
(en)
|
1996-07-15 |
2004-03-02 |
Peter L. Collins |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
|
EP0932684A2
(en)
*
|
1996-09-27 |
1999-08-04 |
American Cyanamid Company |
3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
|
US6248578B1
(en)
|
1997-05-07 |
2001-06-19 |
The Cleveland Clinic Foundation |
Infectious clone for human parainfluenza virus type 3
|
US7632508B2
(en)
|
1997-05-23 |
2009-12-15 |
The United States Of America |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
US7314631B1
(en)
|
1997-05-23 |
2008-01-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
|
US7951383B2
(en)
|
1997-05-23 |
2011-05-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated parainfluenza virus (PIV) vaccines
|
US7208161B1
(en)
|
1997-05-23 |
2007-04-24 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
|
AU7797798A
(en)
*
|
1997-05-23 |
1998-12-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
|
AU2007203671B2
(en)
*
|
1997-05-23 |
2011-09-01 |
The Government Of The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
|
US7192593B2
(en)
|
1997-05-23 |
2007-03-20 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
|
US6410023B1
(en)
|
1997-05-23 |
2002-06-25 |
United States Of America |
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
|
US7201907B1
(en)
|
1997-05-23 |
2007-04-10 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
|
US7250171B1
(en)
|
1997-05-23 |
2007-07-31 |
United States Of America As Represented By The Dept. Of Health & Human Services |
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
|
US20030082209A1
(en)
|
2000-07-05 |
2003-05-01 |
Skiadopoulos Mario H. |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
US7081243B1
(en)
|
1997-07-11 |
2006-07-25 |
Yale University |
Rhabdoviruses with reengineered coats
|
JP4434478B2
(ja)
*
|
1997-07-11 |
2010-03-17 |
イエール ユニバーシティー |
リエンジニアリングされた外被を有するラブドウイルス
|
US6830748B1
(en)
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
BR9911163A
(pt)
|
1998-06-12 |
2002-01-15 |
Sinai School Medicine |
Formulação de vacina, formulação farmacêutica, vìrus atenuado de influenza, processos para vacinar um indivìduo, para prevenir uma doença infecciosa em um indivìduo, e, para tratar ou prevenir tumores em um indivìduo
|
ES2301241T3
(es)
|
1998-06-12 |
2008-06-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Virus de influenza a atenuados, y composiciones inmunogenicas y formulaciones de vacunas que los contienen.
|
EP0974660A1
(en)
|
1998-06-19 |
2000-01-26 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Newcastle disease virus infectious clones, vaccines and diagnostic assays
|
US6146642A
(en)
*
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US7618797B2
(en)
|
1998-12-22 |
2009-11-17 |
Pfizer Inc |
Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
|
US7691389B2
(en)
|
1998-12-22 |
2010-04-06 |
Pfizer Inc |
Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
|
IL144084A0
(en)
*
|
1999-02-03 |
2002-05-23 |
Biosante Pharmaceuticals Inc |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
EP1035205A1
(en)
*
|
1999-03-08 |
2000-09-13 |
Stichting Dienst Landbouwkundig Onderzoek |
Non-spreading pestivirus
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
CA2378552A1
(en)
|
1999-07-09 |
2001-01-18 |
The Government Of The United States Of America |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
|
US7820182B2
(en)
*
|
1999-07-09 |
2010-10-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
|
US8147822B1
(en)
|
1999-09-17 |
2012-04-03 |
Wellstat Biologics Corporation |
Oncolytic virus
|
US6764685B1
(en)
*
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
US6635416B2
(en)
|
2000-04-10 |
2003-10-21 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
JP4791651B2
(ja)
*
|
2000-05-18 |
2011-10-12 |
株式会社ディナベック研究所 |
外来遺伝子導入用パラミクソウイルスベクター
|
CA2322057A1
(en)
*
|
2000-05-18 |
2001-11-18 |
Dnavec Research Inc. |
Paramyxovirus vectors used for transfer of foreign genes
|
JP2004513616A
(ja)
|
2000-06-23 |
2004-05-13 |
ワイス・ホールディングズ・コーポレイション |
改変モルビリウイルスタンパク質
|
CN1455816A
(zh)
*
|
2000-06-23 |
2003-11-12 |
美国氰胺公司 |
从cDNA中挽救犬热病病毒
|
CA2412075C
(en)
|
2000-06-23 |
2011-09-20 |
Ulrike Schmidt |
Attenuated bovine respiratory syncytial virus
|
CN1526014A
(zh)
*
|
2000-10-06 |
2004-09-01 |
��ʽ���������о��� |
用于将外源基因导入骨骼肌的副粘病毒载体
|
JP2002142770A
(ja)
*
|
2000-11-08 |
2002-05-21 |
Dnavec Research Inc |
循環系への遺伝子送達用パラミクソウイルスベクター
|
WO2002098457A2
(en)
*
|
2001-01-17 |
2002-12-12 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
UA93981C2
(ru)
|
2001-01-19 |
2011-03-25 |
Вироновативе Б.B. |
Вирус, который вызывает заболевание дыхательных путей у чувствительных k этому млекопитающих
|
US8715922B2
(en)
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
US20030232061A1
(en)
*
|
2001-10-18 |
2003-12-18 |
Fouchier Ronaldus Adrianus Maria |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
CA2452517A1
(en)
*
|
2001-07-11 |
2003-01-23 |
University Of Miami |
Recombinant vsv for the treatment of tumor cells
|
EP1434862A4
(en)
*
|
2001-07-20 |
2005-04-06 |
Univ Georgia Res Found |
NUCLEOPROTEIC MUTATION-RELATED VIRUS AT A PHOSPHORYLATION SITE FOR OBTAINING A VACCINE AGAINST RABIES AND GENE THERAPY IN THE CENTRAL NERVOUS SYSTEM
|
CA2743750A1
(en)
|
2002-02-21 |
2003-09-04 |
Medimmune, Llc |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus
|
KR101229202B1
(ko)
|
2002-04-26 |
2013-02-01 |
메디뮨 엘엘씨 |
인플루엔자 바이러스의 생산을 위한 다중 플라스미드 시스템
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
FR2839453B1
(fr)
|
2002-05-07 |
2007-05-11 |
Agronomique Inst Nat Rech |
Utilisation de novirhabdovirus modifies pour l'obtention de vaccins
|
CN1820078A
(zh)
*
|
2002-09-09 |
2006-08-16 |
田纳西大学研究基金会 |
弹状病毒的重组突变体及其应用方法
|
US7238357B2
(en)
*
|
2002-11-05 |
2007-07-03 |
Allergan, Inc. |
Methods for treating ulcers and gastroesophageal reflux disease
|
JP2007525178A
(ja)
|
2003-04-25 |
2007-09-06 |
メッドイミューン バクシーンズ,インコーポレイティド |
メタニューモウイルス株、そのワクチン製剤における用途、抗原性配列の発現のためのベクターとしての用途、並びにウイルス増殖方法
|
ES2593082T3
(es)
|
2003-05-28 |
2016-12-05 |
Wisconsin Alumni Research Foundation |
Virus de la gripe recombinantes a título elevado para vacunas y terapia génica
|
JP2007500017A
(ja)
|
2003-06-09 |
2007-01-11 |
ワイス |
cDNAからの非分節型、ネガティブ鎖RNAウイルスの回収のための改良方法
|
US7566458B2
(en)
|
2003-06-16 |
2009-07-28 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
CA2551489C
(en)
*
|
2003-12-23 |
2013-09-03 |
Gregory Duke |
Multi plasmid system for the production of influenza virus
|
AU2004303719B2
(en)
*
|
2003-12-24 |
2010-11-11 |
Intravacc B.V. |
A respiratory syncytial virus with a genomic deficiency complemented in trans
|
US8287878B2
(en)
|
2004-04-09 |
2012-10-16 |
Wyeth Llc |
Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
|
US7504109B2
(en)
|
2004-05-25 |
2009-03-17 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
US8124101B2
(en)
|
2004-06-01 |
2012-02-28 |
Mount Sinai School Of Medicine |
Genetically engineered swine influenza virus and uses thereof
|
JP2006121948A
(ja)
*
|
2004-10-27 |
2006-05-18 |
Kyoritsu Seiyaku Kk |
組換えウイルス
|
JP2008519590A
(ja)
|
2004-11-12 |
2008-06-12 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
組換えニューカッスル病ウィルス
|
JP2008520248A
(ja)
|
2004-11-19 |
2008-06-19 |
ウィスコンシン・アラムナイ・リサーチ・ファウンデイション |
タンデム転写ユニットを有する組換えインフルエンザベクター
|
DE102005006388A1
(de)
|
2005-02-11 |
2006-08-24 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Replikationsdefiziente RNA-Viren als Impfstoffe
|
US8137676B2
(en)
|
2005-02-15 |
2012-03-20 |
Mount Sinai School Of Medicine |
Genetically engineered equine influenza virus and uses thereof
|
EP2471552B1
(en)
|
2005-03-08 |
2015-05-06 |
MedImmune, LLC |
Reassortant influenza viruses
|
US11865172B2
(en)
|
2005-04-21 |
2024-01-09 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
US7959929B2
(en)
|
2005-04-21 |
2011-06-14 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
US20060286591A1
(en)
|
2005-06-21 |
2006-12-21 |
Medimmune Vaccines, Inc. |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
US7790434B2
(en)
|
2005-06-21 |
2010-09-07 |
Medimmune, Llc |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
CA2943039C
(en)
|
2005-10-14 |
2018-11-06 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Rabies virus compositions and methods
|
NZ595736A
(en)
|
2005-12-02 |
2013-05-31 |
Sinai School Medicine |
Chimeric viruses presenting non-native surface proteins and uses thereof
|
WO2007126810A2
(en)
|
2006-03-31 |
2007-11-08 |
Warf - Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
RU2457250C2
(ru)
|
2006-04-19 |
2012-07-27 |
Медиммуне, Ллк |
Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки
|
AU2007240797B2
(en)
*
|
2006-04-20 |
2013-05-23 |
Wyeth Llc |
Purification processes for isolating purified vesicular stomatitis virus from cell culture
|
EP2049662A4
(en)
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
|
CN101983069B
(zh)
|
2006-08-09 |
2014-07-16 |
米迪缪尼有限公司 |
流感血凝素和神经氨酸酶变体
|
US7785874B2
(en)
*
|
2007-01-11 |
2010-08-31 |
The Salk Institute For Biological Studies |
Compositions and methods for monosynaptic transport
|
EP2069484B1
(en)
|
2007-06-18 |
2014-08-13 |
MedImmune, LLC |
Influenza B viruses having alterations in the hemaglutinin polypeptide
|
WO2008156778A2
(en)
|
2007-06-18 |
2008-12-24 |
Tokiko Watanabe |
Influenza m2 protein mutant viruses as live influenza attenuated vaccines
|
US20090186050A1
(en)
*
|
2007-11-16 |
2009-07-23 |
Fouchier Ron A M |
Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
|
CL2008003794A1
(es)
*
|
2007-12-21 |
2009-03-20 |
Wyeth Corp |
Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
|
EP2085092A1
(en)
|
2008-01-29 |
2009-08-05 |
Bayer Schering Pharma Aktiengesellschaft |
Attenuated oncolytic paramyxoviruses encoding avian cytokines
|
RU2523587C2
(ru)
|
2008-07-11 |
2014-07-20 |
МЕДИММЬЮН, ЭлЭлСи |
Варианты гемагглютинина и нейрамидазы вируса гриппа
|
EP2987856B1
(en)
|
2009-02-05 |
2018-07-25 |
Icahn School of Medicine at Mount Sinai |
Chimeric newcastle disease viruses and uses thereof
|
AU2010213966B2
(en)
|
2009-02-12 |
2015-01-22 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
US9051359B2
(en)
|
2009-03-30 |
2015-06-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
WO2011014504A1
(en)
|
2009-07-27 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza virus vectors and uses thereof
|
WO2011014645A1
(en)
|
2009-07-30 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Influenza viruses and uses thereof
|
ES2813347T3
(es)
|
2009-10-26 |
2021-03-23 |
Wisconsin Alumni Res Found |
Virus recombinantes de la influenza de alto título con replicación mejorada en células Vero
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
KR20130075732A
(ko)
|
2010-03-30 |
2013-07-05 |
마운트 시나이 스쿨 오브 메디슨 |
인플루엔자 바이러스 백신 및 이의 용도
|
UA108902C2
(uk)
|
2010-11-10 |
2015-06-25 |
|
Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
|
US9441205B2
(en)
|
2011-06-08 |
2016-09-13 |
Vishwas Joshi |
Two plasmid mammalian expression system
|
ES2953393T3
(es)
|
2011-09-20 |
2023-11-10 |
Icahn School Med Mount Sinai |
Vacunas contra el virus de la influenza y sus usos
|
KR102012109B1
(ko)
|
2012-05-17 |
2019-08-19 |
조에티스 엘엘씨 |
이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
|
BR112015014482A2
(pt)
|
2012-12-18 |
2017-11-21 |
Icahn School Med Mount Sinai |
vacinas para vírus influenza e seus usos
|
MD4655C1
(ro)
|
2013-03-14 |
2020-06-30 |
Icahn School Of Medicine At Mount Sinai |
Virusurile bolii de Newcastle şi utilizarea acestora
|
CN113322264A
(zh)
|
2013-03-14 |
2021-08-31 |
爱默蕾大学 |
具有沉默突变的重组rsv、其相关疫苗和方法
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
AU2014290203B2
(en)
|
2013-07-15 |
2020-12-24 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
|
CA2940570A1
(en)
|
2014-02-27 |
2015-09-03 |
Viralytics Limited |
Combination method for treatment of cancer
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
WO2016118937A1
(en)
|
2015-01-23 |
2016-07-28 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
MX2017010908A
(es)
|
2015-02-26 |
2017-12-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacuna bivalente contra el virus de gripe porcina.
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
CN104962580B
(zh)
*
|
2015-06-30 |
2018-04-27 |
浙江大学 |
一种重组植物弹状病毒载体及其构建方法
|
US9890363B2
(en)
|
2015-07-06 |
2018-02-13 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
WO2017031401A2
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Ns1 truncated virus for the development of canine influenza vaccines
|
US10548966B2
(en)
|
2015-08-20 |
2020-02-04 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
MA42656A
(fr)
|
2015-08-20 |
2018-06-27 |
Univ Cornell |
Vaccin vivant atténué comprenant des mutations de polymérase virale pour le traitement et la prévention de virus de la grippe canine
|
JP7311872B2
(ja)
|
2015-10-29 |
2023-07-20 |
エモリー ユニバーシティー |
キメラrsv、免疫原性組成物、及び使用方法
|
WO2017143236A1
(en)
|
2016-02-19 |
2017-08-24 |
Yoshihiro Kawaoka |
Improved influenza b virus replication for vaccine development
|
CA3026256A1
(en)
|
2016-06-03 |
2017-12-07 |
University Of Rochester |
Equine influenza virus live-attenuated vaccines
|
EP3471767A4
(en)
|
2016-06-15 |
2020-01-15 |
Icahn School of Medicine at Mount Sinai |
INFLUENZA VIRUS HEMAGGLUTININS AND USES THEREOF
|
US11090376B2
(en)
|
2016-12-14 |
2021-08-17 |
Zoetis Services Llc |
Effective vaccination against European strains of porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning
|
EP3606555A4
(en)
|
2017-04-07 |
2021-08-04 |
Icahn School of Medicine at Mount Sinai |
INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
BR112020017354A2
(pt)
|
2018-02-27 |
2020-12-15 |
University Of Rochester |
Composição imunológica multivalente, e, método para induzir uma resposta imune contra uma pluralidade de vírus da influenza equina.
|
CN109136200B
(zh)
*
|
2018-09-20 |
2022-02-18 |
中国水产科学研究院黑龙江水产研究所 |
一种重组传染性造血器官坏死病毒及其构建方法与应用
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
EP3914295A2
(en)
|
2019-01-23 |
2021-12-01 |
Yoshihiro Kawaoka |
Mutations that confer genetic stability to additional genes in influenza viruses
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
WO2020176709A1
(en)
|
2019-02-27 |
2020-09-03 |
University Of Rochester |
Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (eiv) in horses
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
CN113234692B
(zh)
*
|
2021-05-11 |
2022-02-22 |
华中农业大学 |
一种包含狂犬病毒糖蛋白的感染性克隆及应用
|
WO2023227758A1
(en)
|
2022-05-25 |
2023-11-30 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Vaccine with reduced anti-vector antigenicity
|
CN114859064B
(zh)
*
|
2022-06-07 |
2023-04-25 |
中国农业科学院兰州兽医研究所 |
一种牛流行热病毒蛋白复合物及在牛流行热病毒自然感染抗体检测中的应用
|